Related Experiment Videos
Dynamic MR pancreatography after secretin administration: image quality and diagnostic accuracy
Karin J Hellerhoff1, Hermann Helmberger, Thomas Rösch
1Department of Diagnostic Radiology, Technische Universität München, Klinikum rechts der Isar, Ismaninger Strasse 22, D-81675 Münich, Germany.
Objective:
The objective of our study was to assess the improvement of image quality and diagnostic accuracy of secretin-enhanced MR pancreatography compared with conventional MR pancreatography.
Subjects And Methods:
Ninety-five patients were studied with a 1.5-T scanner using a T2-weighted single-slice fast spin-echo sequence. Image quality and diameter of the head, body, and tail portion of the pancreatic main duct, the accessory duct, and the side branches were assessed before and after IV administration of secretin. Diagnoses before and after secretin administration were evaluated in a blinded fashion and correlated to the final diagnoses based on endoscopic retrograde cholangiopancreatography (ERCP), intraoperative results, and clinical follow-up as the reference standard.
Results:
In patients with a normal pancreatic duct, the visualization of all portions of the main pancreatic duct and the accessory duct was significantly improved with dynamic MR pancreatography (p < or = 0.001). In patients with chronic pancreatitis, the visualization of the main duct was also significantly improved with dynamic MR pancreatography (p < or = 0.05). However, the visualization of the minor duct and the side branches was significantly improved only in patients showing no ductal stricture (p < or = 0.05), compared with those with ductal stricture (not significant). The overall sensitivity for the detection of chronic pancreatitis increased from 77% to 89% using secretin-enhanced MR pancreatography. A pancreas divisum was found in eight patients before and 13 patients after secretin administration. The overall negative predictive value of MR pancreatography increased from 84% to 98% after secretin administration.
Conclusion:
Improvement in image quality after secretin stimulation increases the diagnostic value of MR pancreatography in patients with a normal or nondilated main pancreatic duct and may obviate invasive procedures such as ERCP.
Insights
Secretin-enhanced MR pancreatography significantly improves image quality and diagnostic accuracy for pancreatic duct visualization. This enhancement may reduce the need for invasive procedures like ERCP.
Area of Science:
- Radiology
- Gastroenterology
- Medical Imaging
Background:
- Magnetic Resonance (MR) pancreatography is a key imaging technique for evaluating the pancreatic duct system.
- Conventional MR pancreatography has limitations in visualizing fine ductal structures and assessing subtle abnormalities.
Purpose of the Study:
- To evaluate the impact of secretin administration on image quality and diagnostic accuracy of MR pancreatography.
- To compare secretin-enhanced MR pancreatography with conventional MR pancreatography.
Main Methods:
- Ninety-five patients underwent MR pancreatography using a 1.5-T scanner before and after intravenous secretin administration.
- Image quality, pancreatic duct diameter, and diagnostic accuracy were assessed and correlated with reference standards (ERCP, surgery, follow-up).
Main Results:
- Secretin administration significantly improved visualization of the main and accessory pancreatic ducts in normal and chronic pancreatitis patients.
- Sensitivity for detecting chronic pancreatitis increased from 77% to 89% with secretin enhancement.
- The negative predictive value increased from 84% to 98%, aiding in ruling out disease.
Conclusions:
- Secretin-enhanced MR pancreatography enhances diagnostic value, particularly for normal or nondilated ducts.
- Improved visualization may decrease the necessity for invasive diagnostic procedures like ERCP.